Mary, mary, quite contrary, how do your β-cells fail?

Diabetes

Volumn 57, Issue 10, 2008, Pages 2563-2564

  Leahy, Jack L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; DIAZOXIDE; GLUCOSE; INSULIN; SOMATOSTATIN;

CATCH UP GROWTH; CELL LOSS; DIABETOGENESIS; ENDOPLASMIC RETICULUM STRESS; FETUS DEVELOPMENT; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; BLOOD; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL;

EID: 58149330670     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0869     Document Type: Note

References (20)

1. Leahy JL: β-Cell dysfunction in type 2 diabetes mellitus. In Joslin's Diabetes Mellitus. 14th ed. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AL, Smith RJ, Eds. Philadelphia, Lippincott, Williams & Wilkins, 2005, p. 449-461
2. Polonsky KS, Given BD, Van Cauter E: Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81:442-448, 1988
3. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
4. Florez JC: Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100-1110, 2008
5. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414, 1988
6. Matveyenko AV, Veldhuis JD, Butler PC: Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancre-atectomy. Diabetes 55:2347-2356, 2006
7. Kumar AF, Gruessner RWG, Seaquist ER: Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preopera-tive glucose metabolism. Diabetes Care 31:1639-1643, 2008
8. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA: San Antonio metabolism study. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia47:31-39, 2004
9. Chakravarthy MV, Zhu Y, Wice WB, Coleman T, Kappan KL, Marshall CA, McDaniel ML, Semenkovich CF: Decreased fetal size is associated with β-cell hyperfunction in early life and failure with age. Diabetes 57:2698-2707, 2008
10. Leahy JL: β-cell dysfunction with chronic hyperglycemia: the "overworked p-cell" hypothesis. Diabetes Revs 4:298-319, 1996
11. Hansen BC, Bodkin NL: Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 259:R612-R617, 1990
12. Jetton TL, Lausier J, LaRock K, Trotman WE, Larmie B, Habibovic A, Peshavaria M, Leahy JL: Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54:2294-2304, 2005
13. Le Stunff C, Bougneres P: Early changes in postprandial insulin secretion, not insulin sensitivity, characterize juvenile obesity. Diabetes 43:696-702, 1994
14. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE: A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsuline-mia. Diabetes 49:2094-2101, 2000
15. Leahy JL, Bumbalo LM, Chen C: Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43:173-179, 1994
16. Greenwood RH, Mahler RF, Hales CN: Improvement in insulin secretion in diabetes after diazoxide. Lancet 1:444-447, 1976
17. Laedtke T, Kjems L, Porksen N, Schmitz O, Veldhuis J, Kao PC, Butler PC: Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab 79:E520-E528, 2000
18. Song SH, Rhodes CJ, Veldhuis JD, Butler PC: Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. Endocrinology 144:3399 -3405, 2003
19. Turner RC, McCarthy ST, Holman RR, Harris E: Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J 1:1252-1254, 1976
20. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG: The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222-2234, 1985